Posted in | News | Business | Composites

Gurit Wins Wind Turbine Blade Mould Contract

Gurit, a worldwide leading developer and producer of advanced composite materials, technologies and tooling equipment has won a first contract for a wind turbine blade mould to be delivered to a customer in Europe from the Gurit Tooling plant in China.

This European order is another important achievement in the context of Gurit's global Tooling strategy, following shipments of several blade moulds to European-controlled customers in China as well as the delivery of moulds to two customers in India in the current year 2010.

Red Maple, the Tooling Business of Gurit, has signed a first contract for a wind turbine blade mould to be delivered to a customer in Europe. The mould is developed and manufactured at the new production site of Red Maple in Taicang/PR China. This new production facility is especially designed for the manufacture of next-generation blade moulds for wind turbines of up to 7 MW.

Red Maple is the independent, fully-integrated and highly specialized leader in mould manufacturing offering attractively priced, solid quality tooling equipment at very short lead-times.

"The rising interest from international customers in our Tooling offering is very encouraging," commented Rudolf Hadorn, CEO of Gurit.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Gurit Inc. (2019, February 10). Gurit Wins Wind Turbine Blade Mould Contract. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=24671.

  • MLA

    Gurit Inc. "Gurit Wins Wind Turbine Blade Mould Contract". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=24671>.

  • Chicago

    Gurit Inc. "Gurit Wins Wind Turbine Blade Mould Contract". AZoM. https://www.azom.com/news.aspx?newsID=24671. (accessed November 21, 2024).

  • Harvard

    Gurit Inc. 2019. Gurit Wins Wind Turbine Blade Mould Contract. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=24671.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.